Abbvie Inc (NYSE:ABBV) shares traded -1.91% lower at $171.09 on Wall Street last session.
ABBV stock price is now -11.63% away from the 50-day moving average and -4.36% away from the 200-day moving average. The market capitalization of the company currently stands at $302.34B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On October 17, 2024, Bernstein recently initiated its ‘Mkt Perform’ rating on the stock quoting a target price of $203, while ‘HSBC Securities’ rates the stock as ‘Buy’
In other news, Hudson Thomas J, Officer bought 49,170 shares of the company’s stock on Aug 08 ’24. The stock was bought for $9,297,210 at an average price of $189.08. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 05 ’24, EXECUTIVE CHAIRMAN OF BOARD GONZALEZ RICHARD A sold 66,500 shares of the business’s stock. A total of $12,403,580 was realized by selling the stock at an average price of $186.52. This leaves the insider owning 446,599 shares of the company worth $76.41 million. A total of 0.09% of the company’s stock is owned by insiders.
During the past 12 months, Abbvie Inc has had a low of $136.30 and a high of $207.32. As of last week, the company has a debt-to-equity ratio of 11.78, a current ratio of 0.65, and a quick ratio of 0.54. According to the stock market information, the enterprise value for the company is $366417051648, which is based on a 59.67 price-to-earnings ratio, a 7.18 price-to-earnings-growth ratio, and a beta of 0.56. The fifty day moving average price for ABBV is $194.1376 and a two-hundred day moving average price translates $178.85855 for the stock.
The latest earnings results from Abbvie Inc (NYSE: ABBV) was released for 2024-09-30. The net profit margin was 9.15% and return on equity was 56.06% for ABBV. The company reported revenue of $14.46 billion for the quarter, compared to $13.93 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.83 percent. For the current quarter, analysts expect ABBV to generate $14.81B in revenue.
